S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
Log in

NASDAQ:PETSPetmed Express Stock Price, Forecast & News

$32.54
+0.07 (+0.22 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$32.08
Now: $32.54
$32.84
50-Day Range
$30.73
MA: $34.54
$40.53
52-Week Range
$15.12
Now: $32.54
$42.88
Volume397,074 shs
Average Volume679,692 shs
Market Capitalization$659.65 million
P/E Ratio23.08
Dividend Yield3.45%
Beta0.64
PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.
Read More
Petmed Express logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 1.5Dividend Strength: 0.8Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.99 out of 5 stars


Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
Current SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$284.13 million
Cash Flow$1.42 per share
Book Value$6.45 per share

Profitability

Net Income$25.85 million

Miscellaneous

Employees187
Market Cap$659.65 million
Next Earnings Date10/19/2020 (Estimated)
OptionableOptionable
$32.54
+0.07 (+0.22 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Petmed Express (NASDAQ:PETS) Frequently Asked Questions

How has Petmed Express' stock been impacted by Coronavirus?

Petmed Express' stock was trading at $25.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PETS stock has increased by 25.4% and is now trading at $32.54.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Petmed Express?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Petmed Express
.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release its next quarterly earnings announcement on Monday, October 19th 2020.
View our earnings forecast for Petmed Express
.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) issued its quarterly earnings results on Monday, July, 20th. The company reported $0.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by $0.01. The firm earned $96.20 million during the quarter, compared to the consensus estimate of $90.96 million. Petmed Express had a net margin of 9.41% and a return on equity of 21.91%. The firm's revenue was up 20.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.26 EPS.
View Petmed Express' earnings history
.

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express announced a quarterly dividend on Monday, July 20th. Shareholders of record on Friday, July 31st will be given a dividend of $0.28 per share on Friday, August 7th. This represents a $1.12 annualized dividend and a yield of 3.44%. The ex-dividend date of this dividend is Thursday, July 30th.
View Petmed Express' dividend history
.

What price target have analysts set for PETS?

2 brokerages have issued twelve-month price objectives for Petmed Express' shares. Their forecasts range from $20.00 to $31.00. On average, they expect Petmed Express' share price to reach $25.50 in the next twelve months. This suggests that the stock has a possible downside of 21.6%.
View analysts' price targets for Petmed Express
.

Has Petmed Express been receiving favorable news coverage?

Media coverage about PETS stock has been trending somewhat negative on Friday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Petmed Express earned a news sentiment score of -1.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term.
View the latest news about Petmed Express
.

Are investors shorting Petmed Express?

Petmed Express saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 5,350,000 shares, an increase of 27.4% from the April 30th total of 4,200,000 shares. Based on an average daily volume of 651,900 shares, the short-interest ratio is presently 8.2 days. Approximately 27.5% of the company's shares are sold short.
View Petmed Express' Short Interest
.

Who are some of Petmed Express' key competitors?

What other stocks do shareholders of Petmed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Gilead Sciences (GILD), Alibaba Group (BABA), Cisco Systems (CSCO), Netflix (NFLX), Micron Technology (MU), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

Who are Petmed Express' key executives?

Petmed Express' management team includes the following people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.12%), Prudential Financial Inc. (2.10%), Bank of New York Mellon Corp (1.82%), Robeco Institutional Asset Management B.V. (1.74%), Personal Capital Advisors Corp (1.51%) and ProShare Advisors LLC (1.19%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Robert C Schweitzer.
View institutional ownership trends for Petmed Express
.

Which major investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Balyasny Asset Management LLC, Advisor Group Holdings Inc., Hancock Whitney Corp, Cairn Investment Group Inc., North Star Investment Management Corp., Principal Financial Group Inc., and Profit Investment Management LLC. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom, Gian Fulgoni, and Menderes Akdag.
View insider buying and selling activity for Petmed Express
.

Which major investors are buying Petmed Express stock?

PETS stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Prudential Financial Inc., Robeco Institutional Asset Management B.V., ProShare Advisors LLC, Raymond James Financial Services Advisors Inc., Jefferies Group LLC, AJO LP, and Mackay Shields LLC.
View insider buying and selling activity for Petmed Express
.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $32.54.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $659.65 million and generates $284.13 million in revenue each year. Petmed Express employs 187 workers across the globe.

What is Petmed Express' official website?

The official website for Petmed Express is www.1800petmeds.com.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.